US Patent 8969420 Treatment of pervasive developmental disorders with redox-active therapeutics
Patent 8969420 was granted and assigned to Edison Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 29 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 13 Dec, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+427 characters)
Article
Patent abstract
Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD—not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08969420 Treatment of pervasive developmental disorders with redox-active therapeutics US Patent 8969420 Treatment of pervasive developmental disorders with redox-active therapeutics
Infobox
Patent Number
0896942000
Patent Number
896942000
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089694200
Date of Patent
March 3, 2015
0Patent Application Number
141552880
Date Filed
January 14, 2014
0Official Website
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089694200
Date of Patent
March 3, 2015
0Patent Application Number
141552880
Date Filed
January 14, 2014
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 29 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08969420 Treatment of pervasive developmental disorders with redox-active therapeutics
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08969420
Date of patent
March 3, 2015
Patent application number
14155288
Date Filed
January 14, 2014
Patent primary examiner
Find more entities like US Patent 8969420 Treatment of pervasive developmental disorders with redox-active therapeutics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
